About Us CHU Rouen among the first centers in Europe to adopt Valvosoft® technology following its CE marking Jul 9, 2026 HeleneCardiawave 0
Press ReleaseCardiawave confirms the safety of Valvosoft®, its non-invasive ultrasound treatment for aortic stenosis. Jun 14, 2022 READ MORE
Press ReleaseCardiawave announces the authorization by the French National Agency for the Safety of Medicines and Health Products (ANSM) to proceed with a new clinical study in France. May 2, 2022 READ MORE
Press ReleaseCardiawave announces the success of its clinical trial to treat aortic stenosis. Mar 22, 2022 READ MORE
About Us CHU Rouen among the first centers in Europe to adopt Valvosoft® technology following its CE marking Jul 9, 2026 HeleneCardiawave 0
